semaglutide and cardiovascular outcomes in obesity without diabetes journal club New Science Suggests Improves CV Beyond Weight Loss EFFECT OF THE GLP-1 RECEPTOR

Some of the well-known ones include: Ozempic (semaglutide): Approved in 2017 for type 2 diabetes, also commonly used off-label for weight management

That can significantly extend your batterys run time

12 8.4 %, p=0.95)

Human trials of GLP-1 medications in women with PCOS have found (2): Ovulation rates of 86% in women taking GLP-1s alongside metformin - compared to 29% on metformin alone, a threefold improvement 62% of women on GLP-1s had more regular menstrual cycles, versus 28% on placebo Significant reductions in testosterone levels These are meaningful numbers for a condition where restoring ovulation and cycle regularity remains one of the challenges

Coffee no longer needs to be larger, sweeter or more indulgent to earn its place